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Toxic byproducts from infected RBC cause rheological alteration and RBC aggregation. Malaria cul-
ture supernatant has the ability to exhibit RBC aggregation. Ammonium sulfate fractionation and
immunodepletion of methemoglobin from culture supernatant conﬁrmsmethemoglobin as a major
aggregant. In vitro treatment of RBC with methemoglobin induces irreversible high order RBC
aggregates, resistant to shear stress and physical forces. Methemoglobin-mediated ROS generation
in the external micro-environment to develop oxidative stress close to RBC membrane seems to
be responsible for initiating and forming high order RBC aggregates through phosphatidyl-serine
externalization. Removal of oxidative stress through antioxidant treatment abolishes high order
RBC aggregate formation. In conclusion, we discovered a novel pathway of methemoglobin-medi-
ated RBC aggregation and its potential role in patho-physiological effects during malaria.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Malaria caused by Plasmodium falciparum has a high mortality
rate due to anemia, fever, multiple organ damage, renal failure, li-
ver dysfunction and neurological disorders [1–4]. A number of clin-
ical, biochemical and immunological studies tried to explain
patho-physiological mechanisms during malaria but our under-
standing is still limited and underlying molecular events are not
clear [5–9]. The main process responsible for tissue damage and
dysfunction is a mechanical blockage of blood vessels. Vesicular
obstruction is caused by infected RBC adherence to the endothelial
lining of blood vessels and aggregation of uninfected RBC [1].
RBC aggregation during malaria is a complex process governed
by adhesion ligand on infected RBC cells, receptor expression on
uninfected RBC, coagulation factors, platelet mediated agglutina-
tion and plasma proteins [10–16]. The sticky forces between in-
fected and un-infected RBCs slow down micro-circulatory ﬂow
but molecular mechanism and master player are not known.
A number of factors such as changes in shear stress, protein–
protein interactions and erythrocyte membrane charge alteration
regulate the RBC aggregate formation [10,17,18]. During malaria
oxidative insult makes RBC membrane sticky to bind infectedRBC cells expressing pfEMP-1 to form rosettes and aggregates
[19]. In addition, infected RBCs express phosphatidyl serine (PS)
to mimic aged or senescent RBCs and been cleared from circulation
by macrophages [20,21]. Toxic by-products released from infected
RBCs during parasite life-cycle develop pro-coagulant micro-envi-
ronment. Heme released from infected RBC reduces the RBC defor-
mability (RBC-D), an important property of normal RBC to pass
through the small capillaries and avoid splenic clearance [22]. Both
infected and normal RBC lysis releases large amount of hemoglobin
in the blood. Hemoglobin released from ruptured RBC is oxidized
by molecular oxygen to form methemoglobin (metHb). Extracellu-
lar metHb further accelerates the RBC lysis to contribute into ele-
vated levels of metHb and hemoglobin degradation products
[23]. Methemoglobin exposure to the endothelial cells produces a
number of inﬂammatory markers and cellular adhesion molecules
to promote endothelial cell-RBC adhesion [24–26]. In the current
study, we explored the potential role of methemoglobin present
in infected serum to cause RBC aggregation and its mechanism.
Our results indicate that pseudo-peroxidase activity associated
with methemoglobin causes production of free radicals to induce
oxidative stress within RBC. Oxidative stress within RBC causes
phosphatidyl serine (PS) externalization to generate sticky patches
to initiate aggregation [27]. Hence methemoglobin induces RBC
aggregation through membrane modiﬁcation by oxidative stress
mediated PS externalization.
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2.1. Materials
Methemoglobin (M4257), N-acetyl cysteine (A2750), Mannitol
(N9647), 2,7,dichloroﬂuroscein diacetate (35845), glutaraldehyde
(EM grade) 25% (G6257), clotrimazole (C6019), annexin-V-FITC
apoptosis detection kit (APOAF-20TST), were procured from Sigma,
Vitamin C, hydrogen peroxide, thiourea, DMSO, were procured
from Merck. anti-Hb antibody and an isotype control antibody
(IgG) was purchased from santacruz biotechnology, Inc. Other
chemicals were of analytical grade.
2.2. Preparation of RBC from human blood
Human blood was collected from healthy donors of either sex,
age (20–30 years) from a right arm vein under aseptic conditions
in an EDTA containing tubes. Whole blood was centrifuged at
1000 rpm and RBC pellet was washed with PBS containing glucose
(1 mg/ml) and cells from the top layer containing WBCs were re-
moved. A thin smear was made on a glass slide to monitor the pur-
ity of RBC preparations. In all of the experiments, we have used
RBC preparations with less than 1% other blood cells.
2.3. Measurement of RBC aggregation
RBC preparations (5% hematocrit) were treated with different
concentration of metHb (0–1 mg/ml) and RBC aggregation was
determined by light microscopic observation of thin stained blood
smear as described before [28].
2.4. Flow cytometric determination of the ROS level in RBC
ROS level in RBC treated with metHb was determined as de-
scribed previously [23]. In brief, RBCs were loaded with 10 lM
ﬂuorescent probe 2,7,dichloroﬂuorescein diacetate (DCFH-DA) for
1 h at 37 C in the dark. RBCs were washed 3 times with PBS to re-
move excess DCFH-DA and treated with metHb (0.7 mg/ml) for
15 min at 37 C. After treatment all samples were kept on ice and
analyzed in FACS Caliber (BD Biosciences) to detect ROS containing
RBC population. In similar conditions, control cells were also
analyzed.
2.5. Preparation of clotrimazole modiﬁed methemoglobin (CLT–
MetHb)
Methemoglobin (10 mg/ml), clotrimazole (20 mM) and hydro-
gen peroxide (1 mM) solutions were mixed together in a glass bea-
ker in a ratio of 120:6:1 with constant shaking for 30 min at 25 C.
The reaction volume was dialyzed against PBS (pH7.4) for 24 h
with four changes. Concentration of clotrimazole modiﬁed methe-
moglobin (CLT–MetHb) was adjusted to 7 mg/ml and stored at
80 C in small aliquots for future use.
2.6. Determination of phosphatidyl serine (PS) level on RBC surface
RBC surface phosphatidyl serine (PS) level was determined as
described previously [29]. For PS localization on RBC aggregates,
a small aliquot of RBCs from PS expression studies were used to
prepare a thin smear on a glass slide and observed with ﬂuores-
cence microscope 80Ti (Nikon) under 40 objective. Control cells
were similarly processed and analyzed. Files were opened in Adobe
Photoshop 7.0 and gray levels were adjusted by using the autolevel command with black and white clip set to 0%. The images
were cropped again and scaled for ﬁnal display.
2.7. Analysis of RBC aggregates in scanning electron microscope
RBC hematocrit (5%) treated with metHb (0.2 mg/ml) for 1 h at
37 C and samples for scanning electron microscope (SEM) were
prepared as mentioned earlier with minor modiﬁcation [30]. In
brief, metHb treated or untreated cells were washed with PBS
and ﬁxed in 1% glutaraldehyde solution for 24 h at 4 C. Cells were
washed twice with 0.1 M phosphate buffer and were dehydrated
with graded ethanol from 50% to 100% in a vacuum environment.
Samples were coated with gold ﬁlm in a Polaron sputter coater.
A total of 10 ﬁelds were identiﬁed randomly and observed with
ﬁeld emission scanning electron sigma zeiss (Carl zeiss). The
instrumental setting such as EHT, width and signal were 7 kV,
3.6 mm and inLens respectively.
2.8. Preparation of parasite culture supernatant
Plasmodium falciparum strain 3D7 was grown in RPMI 1640 sup-
plemented with antibiotics and serum as described previously
[31]. RBCs were separated from parasite culture (5% parasitemia
and a mixed population of different RBC stages) by centrifugation
(with slow acceleration to avoid RBC lysis) at 700 rpm and culture
supernatant was collected. Supernatant was preserved at –80 C
for future use.
2.9. Ammonium sulfate fractionation of parasite culture supernatant
The parasite culture supernatant was clariﬁed by passing
through 0.22 lm ﬁlter to remove cellular debris and particulate
matter. The clariﬁed supernatant was subjected to 65% ammonium
sulfate saturation, centrifuged at 15000 rpm to separate pellet (P1)
and supernatant. The resulting supernatant was further fraction-
ated with 85% ammonium sulfate saturation, centrifuged at
15000 rpm to separate pellet (P2) and supernatant (S2). Pellet frac-
tions were re-suspended in PBS and all the fractions were dialyzed
against PBS with three changes to remove ammonium sulfate. The
dialyzed fractions were checked for their ability to induce RBC
aggregation as described. MetHb concentration in each fraction
was determined as described previously [32].
2.10. Measurement of methemoglobin level
Methemoglobin level was measured in parasite culture super-
natant as described earlier [32].
2.11. Preparation of methemoglobin deprived parasite culture
supernatant
Human Hb antibody (Santacruz) was coupled on CN–Br acti-
vated Sepharose column following manufacturer instructions. Fil-
tered sterile parasite culture supernatant was loaded onto the
anti-Hb column at 0.5 ml/min ﬂow rate and ﬂow-through was col-
lected in a separate tube at 4 C. In a parallel setup, a non-speciﬁc
primary control antibody is coupled on CN–Br activated column
and parasite culture supernatant was passed. Flow through from
both columns were used to determine metHb level and their ability
to cause RBC aggregation.
2.12. Statistical analysis
Statistical analysis was performed using the student t-test
(Microsoft excel) and a P-value <0.05 was considered signiﬁcant.
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3.1. Methemoglobin is an aggregant present in parasite culture
supernatant
The amount of methemoglobin in control culture media and
parasite culture supernatant was measured by the method de-
scribed previously [32]. The amount of methemoglobin in control
culture media and parasite culture supernatant was 0.08 ± 0.021
and 0.18 ± 0.02 mg/ml respectively. Parasite culture supernatant
causes RBC aggregation and rouleau formation in a microscopic
RBC aggregation assay (Fig. 1A). The culture supernatant obtained
from the uninfected RBCs incubated in complete media (RPMI
1640 supplemented with antibiotics and human serum) has very
little RBC aggregation activity (Fig. 1A). Human serum used to cul-
ture parasite and RBCs used in aggregation assays are compatible
(from the same individual or with similar blood group) to exclude
the contribution of serum components in promoting non-speciﬁc
RBC aggregation. The parasite culture supernatant is a mixture of
serum components, parasite derived proteins, heme, hemoglobin
degradation (a-chain and b-chain) and methemoglobin [33,34].
Extensive dialysis of parasite culture supernatant against PBS with
a 12.5 KDa cut off membrane removes small molecular weight
molecules and salt present in parasite culture supernatant. It re-
duces the aggregation activity of parasite culture supernatant by
16.25% (Table 1). This is probably be the contribution of small
molecular weight factors, heme present in the parasite culture
supernatant. An ammonium sulfate fractionation of dialyzed cul-
ture supernatant was done as outlined in Fig. 1B. RBC aggregation
activity and amount of methemoglobin present in each fraction is
determined as given in Section 2. An ammonium sulfate fraction-
ation of parasite culture supernatant gives different fractions (P1,
P2 or ﬁnal supernatant S2) with varying amount of methemoglo-
bin. The total RBC aggregation of the pellet fractions P1 & P2 was
43.23% and 52.67% respectively in comparison to total activity
(100%) present in culture supernatant where as supernatant frac-
tion (S2) contains no RBC aggregation activity (Table 1). The level
of methemoglobin and RBC aggregation activity in different frac-
tions indicates the probable role of methemoglobin in RBC aggre-
gation during malaria. An identical ammonium sulfate
fractionation strategy was performed with the supernatant from
control culture obtained from the uninfected RBCs incubated in
complete media (RPMI 1640 supplemented with antibiotics and
human serum) to rule out contamination of metHb from RBC lysis
during the procedure. No signiﬁcant RBC aggregation activity was
found in control puriﬁcation (Data not shown). To further conﬁrm
with a speciﬁc tool, parasite culture supernatant was passed
through an afﬁnity column with anti-Hb antibodies coupled to Se-
pharose beads, to remove metHb speciﬁcally from the culture
supernatant. A control afﬁnity puriﬁcation with anti-IgG control
antibodies coupled to Sepharose beads was performed to exclude
non-speciﬁc antibody effects. The metHb level in ﬂow through
from anti-Hb is signiﬁcantly low as compare to ﬂow through from
control afﬁnity puriﬁcation (Table 1). Interestingly, immunodeple-
tion of metHb from parasite culture supernatant drastically re-
duces the RBC aggregation (3%) where as ﬂow through from
control afﬁnity puriﬁcation with anti-IgG antibodies has similar
degree of aggregation (80%) as crude parasite culture superna-
tant. A 20% decrease in activity might be due to partial denatur-
ation of metHb or removal of other small aggregant such as
heme or hemozoin. To further understand the potential of other
pro-oxidant molecules present in parasite culture supernatant,
RBCs were exposed to heme, heme–BSA (to mimic degraded hemo-
globin or peptide associated heme), metHb and RBC aggregationwas measured as described in Section 2. As expected, heme or
heme–BSA induces RBC aggregation but free heme is more potent
than heme–BSA complex (Fig. 1C). Hence, a combination of generic
salt fractionation and subtractive approach gives clear indication of
metHb as a factor present in parasite culture supernatant respon-
sible for RBC aggregation. An extensive study might help to unravel
the role of other factors present in the parasite culture supernatant
and their relative contribution.
Level of methemoglobin reported in the previous studies varies
from 1–3.5 mg/ml and it depends on factors such as different par-
asite strain, level of parasitemia, host age (young/old, child or preg-
nant women etc.), sex [35,36]. Therefore a wide range of
methemoglobin (0.2–1 mg/ml) is used in an in vitro RBC aggrega-
tion assay to explore the role of exogenous metHb in RBC aggrega-
tion. Methemoglobin exposure causes aggregation and rouleau
formation in a concentration dependent manner. RBC aggregates
were further analyzed to correlate methemoglobin dosage with
the complexity of aggregates. Lower order aggregates (2 or 3 cells
per aggregate) were more common at a low methemoglobin con-
centration whereas the RBC number within aggregate increases
with methemoglobin concentration. High concentration speciﬁ-
cally induces formation of middle order (5–9 cells per aggregate)
or high order aggregate (more than 10 cells per aggregate). RBCs
exposed to PBS under identical conditions exhibit a very low level
of aggregates (Fig. 1D). RBC aggregates in the presence of high met-
hemoglobin concentration (>0.4 mg/ml) were showing branching
and de-branching to give the complex nature of the aggregates
(Fig. 1E). RBC treated with PBS exhibits a homogenous red colored
clear reaction mixture with no visible RBC clumps where as RBC
treated with increasing concentration of methemoglobin (0–
1 mg/ml) shows precipitated material containing RBC aggregates.
(Fig. 1F). The complex RBC aggregates are more potent in blocking
blood vessels and capillaries [1].
3.2. 2-Methemoglobin mediated oxidative insult causes RBC
aggregation
RBCs exposed to parasite culture supernatant causes develop-
ment of ROS level compared to control RBCs (Fig. 2A). To explore
the role of ROS development as a mechanism behind RBC aggrega-
tion, ROS level and RBC aggregation were measured in methemo-
globin (0.7 mg/ml) treated RBCs. RBC treated to methemoglobin
exhibits high ROS compared to PBS treated cells (Fig. 2B). Both
parameters were correlated well (r2 = 0.92, n = 4) especially in
the initial high ROS phase (spike) where cells exhibit a sharp rise
in the aggregation (Fig. 2C). To further conﬁrm the role of ROS in
the process of aggregation, RBCs was pre-incubated with antioxi-
dant or free radical scavenger to remove ROS spike and treated
with methemoglobin, RBC aggregation and ROS level were mea-
sured as described in the Section 2. Vitamin C, N-acetyl cysteine,
thiourea are antioxidant molecules used to reduce cellular oxida-
tive stress by scavenging oxygen centered radicals such as hydro-
xyl radicals, superoxide radicals [37]. DMSO, mannitol is mainly
being used as a radical scavenger in several studies to reduce the
level of free radicals [38,39]. Antioxidant/free radical scavenger
treatment abolishes methemoglobin mediated RBC aggregation
(Table 2). Interestingly, they were more active against methemo-
globin mediated higher order RBC aggregates (5–10 RBCs in each
aggregate) than lower order aggregates (Table 2). Even DMSO
and mannitol, less potent against RBC aggregation were potent to
inhibit high order RBC aggregation (P < 0.0001). High order aggre-
gate is mainly responsible for blood vessel blockage and associated
with the development of patho-physiology of methemoglobin
toxicity. In addition, antioxidants or free radical scavengers are
Fig. 1. Methemoglobin present in the parasite culture supernatant causes irreversible RBC aggregation. (A) RBCs exposed to supernatant from control media (RPMI 1640
containing 1% antibiotics, 0.5% human serum) or supernatant from parasite culture (5% parasitemia) induces RBC aggregation. RBC aggregation by supernatant from control
media and parasite culture was measured as described in Section 2. RBC aggregation in supernatant from control media was considered as 100% and aggregation in
supernatant from parasite culture was expressed accordingly and it was statistically signiﬁcant (P < 0.01). RBCs (blood group used) and human serum in culturing P.
falciparum 3D7 strain was from the same source and compatible with each other. (B) Ammonium sulfate fractionation strategy of parasite culture supernatant. (C) RBC
aggregation activity of different pro-oxidant molecules. 5% RBC hematocrit was exposed to PBS (control), heme (100 lM), heme–BSA complex (100 lM), methemoglobin
(1000 lg/ml) and RBC aggregation was measured as described in Section 2. All error bars indicate standard deviation (S.D.) and it was statistically signiﬁcant (Control vs
heme, P < 0.0001; Control vs heme–BSA, P < 0.000046). (D) Methemoglobin dose dependently causes high degree RBC aggregates with different number of RBCs (2–10) per
aggregates. 5% RBC hematocrit was treated with different concentration of methemoglobin as indicated (in lg/ml) and RBC aggregation as well as the number of cells present
in each aggregate was calculated. RBCs treated with PBS considered as control and used to calculate fold change in methemoglobin treated samples. All error bars indicate
standard deviation (S.D.) and were calculated from triplicate measurements (n = 5). (E) RBCs treated with different concentration of methemoglobin as in (D) and a small
aliquot of the assay mixture was used to prepare the smear to visualize the aggregates and the number of cells present in each aggregate. Methemoglobin exposed RBCs form
complex aggregates with branching and de-branching as indiacted by arrow in each panel. (F) Visualization of RBC aggregates in an in vitro aggregation assay. 5% RBC
hematocrit treated with PBS or different concentration of methemoglobin as indicated (in lg/ml) and a small aliquot of assay mixture was poured on glass slides and images
of visible RBC clumps were captured with a high resolution camera (Nikon, L22). RBCs treated with PBS serve as control and exhibits no visible clumps.
S.N. Balaji, V. Trivedi / FEBS Letters 587 (2013) 350–357 353blocking parasite culture supernatant mediated RBC aggregation as
well (Fig. 2D). More-interesting, the inhibition was speciﬁc to-
wards high order aggregation and does not affect aggregation in-
duced by control culture supernatant (Fig. 2D). RBCs treated with
antioxidant and radical scavengers used in current study does
not cause any RBC aggregation especially high order aggregates
(Table 2).3.3. Pseudo-peroxidase activity of methemoglobin makes RBC
membrane sticky through phosphatidyl-serine externalization
Methemoglobin has ability to generate reactive oxygen species
(ROS) in the microenvironment through a low level of peroxidase
activity [40]. Probing the role of peroxidase activity of methemo-
globin associated with RBC aggregation, we constructed a
Table 1
RBC aggregation activity of different fractions from parasite culture supernatant.
S. no. Conditions Total MetHb (%) RBC aggregation activity (%) ± SD
1 Parasite culture supernatanta 100.00 ± 8.31 100.0 ± 5.63
2 Parasite culture supernatant (Dialyzed) 96.33 ± 4.71 83.75 ± 3.45
3 Pellet 1 (P1) 38.88 ± 3.94 43. 23 ± 5.61
4 Pellet 2 (P2) 41.55 ± 7.81 52.67 ± 3.43
5 Supernatant (S2) 02.66 ± 1.23 0 ± 1.67
Immuno-depletion of methemoglobin from parasite culture supernatant
6 Flow Through (anti-Hb antibody) 3.14 ± 0.31 3.12 ± 1.67
7 Flow Through (anti-IgG antibody) 93.12 ± 3.12 78.51 ± 3.18
The parasite culture supernatant was subjected to ammonium sulfate fractionation as outlined in Fig. 1B and all the fractions were dialyzed against PBS with three changes to
remove ammonium sulfate. The dialyzed fractions were checked for their ability to induce RBC aggregation and level of methemoglobin as described in Section 2.
a The level of methemoglobin in parasite culture supernatant is 0.18 ± 0.02 mg/ml (100%) and used to express methemoglobin for other fractions. In another experiment,
methemoglobin was immune-depleted from parasite culture supernatant by passing through an afﬁnity column of anti-Hb antibodies coupled to CN–Br activated Sepharose
beads. A control afﬁnity puriﬁcation with anti-IgG control antibodies coupled to CN–Br activated Sepharose beads was performed to monitor non-speciﬁc antibody effects.
Fig. 2. Methemoglobin induces oxidative stress within RBC and development of oxidative stress correlates with RBC aggregation. (A) RBCs were loaded with 10 lM
ﬂuorescent ROS probe 2,7,dichloroﬂuorescein diacetate and treated with supernatant from control media (control) or supernatant from parasite culture. (B) RBCs were loaded
with 10 lM ﬂuorescent ROS probe 2,7,dichloroﬂuorescein diacetate and treated with PBS (control) or methemoglobin. 10000 RBCs were analyzed in ﬂow cytometry to detect
the ROS containing RBC population. RBCs exposed to supernatant from parasite culture or methemoglobin induces intracellular ROS as indicated by ﬂow cytometric analysis.
(C) RBC population with high level of ROS level correlate well with RBC aggregation (r2 = 0.92). RBCs exposed to PBS (control) was used to calculate fold change. All error bars
indicate standard deviation (S.D.) and were calculated from triplicate measurements (n = 4). A 2-tail paired student t-test between control and methemoglobin gives
P = 0.000748. (D) Antioxidant/free radical scavenger treatment abolishes parasite culture supernatant mediated RBC aggregation. RBCs were pre-incubated with vitamin C
(60 lM), N-acetyl cysteine (5 mM), thiourea (0.5%), DMSO (0.2%), mannitol (5%) for 30 min at 37 C and treated with parasite culture supernatant. RBC aggregation was
measured as described in Section 2 and RBC aggregation in supernatant from control media (control) is used to calculate fold change. Experiments were performed in
triplicate and values were expressed as fold change in RBC aggregation ± standard deviation (S.D.). A 2-tail paired student t-test indicates the RBC aggregation was statistically
signiﬁcant with P < 0.0001 (control vs infected media), P < 0.001 (infected media vs antioxidants).
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where clotrimazole irreversibly binds to the heme part of methe-
moglobin and abolishes its peroxidase activity. Clotrimazole mod-
iﬁed methemoglobin (CLT–MetHb) did not produce signiﬁcant ROS
in the microenvironment where as methemoglobin produced ROS
in a dose dependent manner (Data not shown). CLT–MetHb was
not robust to cause RBC aggregation (Fig. 3A) but still had the
ability to induce lower degree RBC aggregates (2 or 3 cells peraggregates) but higher order aggregates (>5 cells per aggregate)
were absent (Table 2). During eryptosis, RBCs express high levels
of Phosphatidyl serine (PS) on their plasma membrane [41]. PS
externalization is associated with RBC aggregation in obese pa-
tients [29]. To explore such a possibility we measured the expres-
sion of PS on the RBC membrane using a PS speciﬁc ﬂuorescent
label, Annexin V-FITC. RBCs were exposed to metHb, CLT–MetHb
or PBS (control) for 15 min and stained with Annexin V-FITC for
Table 2
Effect of different antioxidant on methemoglobin mediated RBC aggregation.
S. no. Conditions RBC aggregation ± S.D. Degree of aggregation ± S.D.
RBCs > 2 RBCs > 5
1 Methemoglobin (MetHb) 43.7 ± 5.9 19.48 ± 7.3 9.61 ± 3.4
2 CLT–methemoglobina 25.2 ± 7.9 35.45 ± 7.3 4.54 ± 7.3
3 MetHb + Vitamin C 24.9 ± 2.4 12.13 ± 5.6 0.00 ± 1.2
4 MetHb + N-acetyl cysteine 22.8 ± 3.1 16.31 ± 4.3 0.37 ± 0.25
5 MetHb + Thiourea 29.8 ± 3.9 13.62 ± 3.6 2.21 ± 1.2
6 MetHb + DMSO 37.4 ± 8.3 20.04 ± 4.2 4.76 ± 3.21
7 MetHb + Mannitol 44.7 ± 4.5 19.41 ± 3.2 1.20 ± 2.13
8 RBC + Vitamin C 26.9 ± 5.3 0 ± 2.2 0 ± 1.42
9 RBC + N-acetyl cysteine 27.9 ± 5.9 0 ± 1.2 0 ± 2.16
10 RBC + Thiourea 29.6 ± 3.4 0 ± 2.3 0 ± 3.12
11 RBC + DMSO 35.0 ± 2.1 12.48 ± 3.4 0.92 ± 2.42
12 RBC + Mannitol 31.1 ± 1.8 5.36 ± 1.7 1.20 ± 3.18
RBCs were pre-incubated with Vitamin C (60 lM), N-acetyl cysteine (5 mM), Thiourea (0.5%), dimethyl sulphoxide (0.2%), mannitol (5%) for 30 min at 37 C and treated with
methemoglobin (0.8 mg/ml) for 15 min and RBC aggregation was measured as described in Section 2. RBC aggregation in PBS treated sample was considered as control
(30.5 ± 3.2). Experiments were performed in triplicate and values were expressed as %RBC aggregation ± standard deviation (S.D.).
a CLT–methemoglobin is a clotrimazole modiﬁed methemoglobin (inactive methemoglobin) where clotrimazole irreversibly binds to the heme part of methemoglobin and
abolishes its peroxidase activity. A 2-tail paired student t-test indicates the RBC aggregation was statistically signiﬁcant with P < 0.001 (control vs methemoglobin), P < 0.0001
(methemoglobin vs antioxidants).
Fig. 3. Methemoglobin associated peroxidase activity causes phosphatidyl Serine (PS) externalization and RBC aggregation. RBC cells exposed to either MetHb or CLT–MetHb
(inactive MetHb) and (A) RBC aggregation, (B) expression of PS on the membrane and (C) localization of PS on RBC aggregates was performed. (D) Observation of RBC
aggregates in scanning electron microscopy. RBCs exposed to MetHb forms aggregates with a deﬁned pattern of attachment points on the membrane (magniﬁcation; 1000,
scale bar = 20 lm). Zoom view of RBC aggregate with arrow head indicating attachment sites involved in aggregation (magniﬁcation; 12000, scale bar = 2 lm). (E) Effect of
pH on MetHb induced RBC aggregation. A decrease in RBC aggregation was observed on both sides of neutral pH (acidic/basic) was statistically signiﬁcant (P < 0.02). All error
bars indicate standard deviation (S.D.) and were calculated from triplicate measurements.
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ences). RBC exposed to PBS serve as control and exhibits very
low level of ﬂuorescence. MetHb treated RBCs show more than
60% population with ﬂuorescent Annexin V-FITC staining
(Fig. 3B). In contrast, CLT–MetHb treated RBCs exhibit a low level
of PS staining compared to control cells. In localization study,
metHb treated RBCs give high intense PS staining of plasma mem-
brane, predominantly present in high order RBC aggregates
(Fig. 3C, MetHb). Highly ﬂuorescent PS positive RBCs present inlow order aggregates was surrounded by PS negative low ﬂuores-
cent RBCs. It is speculative that high PS expressing RBCs might
be a nucleating aggregation process. RBCs exposed to PBS or
CLT–MetHb did not show any signiﬁcant PS staining on their mem-
brane but these sample exhibits lower level aggregates and rouleau
formation (Fig. 3C, CLT–MetHb or PBS).
Phosphatidyl serine expression of outer RBC membrane induces
a negative charge on the plasma membrane. To testify the role
of charged patches on the outer membrane in aggregation, RBC
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SEM microscope. A low resolution (1000) observation of RBC
aggregates indicates high order aggregates (>5 cells per aggre-
gates) conﬁrming our previous optical microscopic study
(Fig. 3D). RBC aggregates at high resolution (12000) exhibits
RBC-RBC clumping involves discrete attachment points on the
adjacent RBC membrane (Fig. 3D, Inset). In an aggregate, RBCs
are sharing a large surface area with each other but are entangled
with the speciﬁc attachment points between them. To further val-
idate the role of patches on the RBC membrane due to PS external-
ization, metHb mediated RBC aggregation experiment was
performed at different pH (acidic and basic side), calculated the
change in RBC aggregation from neutral pH 7. RBCs were treated
with MetHb (0.7 mg/ml) for 1 h in buffered saline solution of dif-
ferent pH (4–10) and RBC aggregation was measured as described
in the Section 2. RBCs suspended in each pH solution without met-
hemoglobin served as control for particular pH and used to calcu-
late percentage change. RBC aggregation with metHb at pH 7.0 was
28.3% compared to untreated control as 14%. A 15–20% decrease in
aggregation was observed in both acidic and basic pH solutions
in comparison to aggregation at neutral pH (Fig. 3D). The variation
in RBC aggregation in basic or acidic pH from neutral pH was
statistically signiﬁcant with P < 0.02. It clearly indicates involve-
ment of plasma membrane modiﬁcation (changes in polarity or
development of charge) with RBC aggregation.
4. Discussion
RBC aggregation is a physiological event required for maintain-
ing normal homeostasis of the body. RBCs have the tendency to
collide with each other within a blood vessel during ﬂow to form
lower level aggregates containing 2 or 3 cells but these aggregates
are very weak and disintegrate when passes through high shear
stress. Under patho-physiological conditions, reaction or factors
favoring RBC aggregation results into formation of big RBC aggre-
gates, responsible for vesicular blockage and tissue damage [14].
In the present study we have been exploring the methemoglobin
present in parasite culture supernatant as a factor to cause RBC
aggregation. A partial puriﬁcation of parasite culture supernatant
indicates correlation of methemoglobin amount present in differ-
ent fractions with RBC aggregation but possibility of different ac-
tive factors in similar proportions cannot be ruled out. In an
in vitro RBC aggregation assay, metHb causes dose dependent
RBC aggregation in a serum free micro-environment (Fig. 1). It
preferentially induces formation of higher order RBC aggregates
(5–10 cells per aggregate) and these effects were linked to the
development of oxidative stress within RBC (Figs. 2 and 3). Treat-
ing the RBCs with antioxidant protects the RBCs to form aggre-
gates, speciﬁcally high order aggregates (Table 2). Interestingly,
lower order aggregates were mostly present in PBS treated RBCs
and mimics physiological conditions. Hence, it is clear that antiox-
idant will help in breaking/inhibiting formation of bigger RBC
aggregates but it does not affect physiological RBC aggregation.
Antioxidant therapy with N-acetyl cysteine (NAC) in cerebral ma-
laria reduces inﬂammation at the tissue injury site to delay the dis-
ease progression and helps faster recovery but in other reports NAC
treatment is ineffective [42–44]. It implies that NAC dosing proba-
bly be a critical factor to decide the ﬁnal outcomes. As NAC treat-
ment does not interfere with the regular anti-malarial
chemotherapy and can be proposed as an adjuvant therapy during
malaria [22]. Our study highlights another facet of the potential
beneﬁcial role of antioxidants as an adjuvant therapy during cere-
bral malaria.
Methemoglobin contains heme as prosthetic group with an iron
(Fe3+). Due to which it can be able to catalyze peroxidationreactions to oxidize aromatic and halide substrates [45]. Unlike
classical peroxidases, methemoglobin is not well equipped to han-
dle single electron generated on heme, as a result electron are ex-
changed with the electron donor in the micro-environment and
produces free radicals [46]. But the nature of electron donors pres-
ent in the micro-environment and its exchange mechanism with
electron from MetHb is not known and it is beyond the scope of
the current study. A close relationship was found between peroxi-
dase activity, ROS accumulation in the external microenvironment
and RBC aggregation (Fig. 3). RBCs are well equipped with the pow-
erful antioxidant system and it is difﬁcult to develop oxidative
stress within RBC but studies indicate that during RBC aging met-
hemoglobin mediated ROS production causes development of oxi-
dative stress [47]. Oxidative stress in RBC causes membrane
protein modiﬁcation resulting in development of charge on the
outer membrane. In addition, phosphatidyl serine externalization
provides hydrophobic patches on the plasma membrane. This
makes RBCs more likely to aggregate by making membrane sticky
(Fig. 3C). Sensitivity of RBC aggregation to the different pH indicate
a direct relationship between charge/membrane polarity with
aggregation process (Fig. 3D). Two different models, bridging mod-
el and depletion model are proposed to explain RBC aggregation
[17]. Preliminary results indicate that methemoglobin induced
RBC aggregation follows bridging model and a PS externalization
might play a role to disrupt disaggregation forces and initiate the
aggregation reactions. But we have not performed rigorous
validation of models or role of PS externalization with the RBC
aggregation and precise mechanistic details of the process might be
multi-factorial in nature and beyond the scope of the current study.
Presence of methemoglobin in the blood is known to contribute
malaria associated patho-physiological conditions but methemo-
globenia is associated with other disease conditions too. A number
of such conditions exhibit RBC aggregation but still it is not true for
all of the patho-physiological conditions with high methemoglobin
level [14,48,49]. In addition, obese patient exhibits a high level of
RBC aggregation but do not develop a high level of methemoglobin
[29]. RBC aggregation is a multifactorial event and that is made
conditions even more complicated to explore. The ﬂow of blood
or shear stress can be one such factor to decide whether RBC will
form stable aggregates or RBC aggregates will form but disinte-
grate afterwards. A detailed study is required to test the physiolog-
ical relevance of other factors required for RBC aggregation and
which is beyond the scope of the current study.
In the current study, we discovered a novel pathway of methe-
moglobin mediated RBC aggregation in P. falciparum infected
blood. Antioxidant treatment abolishes the methemoglobin medi-
ated high order RBC aggregate formation and gives new insight
into their role as adjuvant therapy. Presence of methemoglobin
in the blood is known to contribute malaria associated patho-phys-
iological conditions but further studies are required to test the
physiological relevance of methemoglobin mediated RBC aggrega-
tion with severity of cerebral malaria and tissue damage.
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